C41	No association between prenatal PrEP exposure and adverse growth outcomes among Kenyan infants: a prospective study	E-poster	PrEP and pregnant women
B59	No age-related difference in dolutegravir metabolic glucuronidation ratio in children between 3 months and 18 years old in the ODYSSEY trial	E-poster	Pharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations
B37	NNRTI MK-8507 does not alter the pharmacokinetics of the combined oral contraceptive levonorgestrel/ethinyl estradiol	E-poster	Drug interactions
C32	Next generation 3D-printed intravaginal rings for prevention of HIV and unplanned pregnancy	E-poster	Novel delivery systems (e.g., rings, implants, transdermal systems)
B45	New generation of HYBRID CAR-T cells efficiently kill HIV infected cells and neutralize cell-free virus	On-demand oral abstract session	Immune-based therapy trials
A6	Neutralizing antibody induction associated with a germline immunoglobulin gene polymorphism in rhesus macaques after neutralization-resistant SIVsmE543-3 infection	E-poster	Humoral immunity (including broadly neutralizing antibodies)
B67	Neuropsychiatric manifestations and sleep disturbances in children and adolescents randomised to dolutegravir-based ART vs standard-of-care in the ODYSSEY trial	On-demand oral abstract session	Mental health and neurocognition in paediatric and adolescent populations
C41	Navigating PrEP use and pregnancy: perspectives among adolescent girls and young women (AGYW) in Tshwane, South Africa	E-poster	PrEP and pregnant women
A18	Naive infection predicts HIV reservoir size and diversity in individuals with a spectrum of immunological control	E-poster	Cellular and tissue reservoirs of HIV/SIV
A18	Naïve CD4+ T cells form the bulk of the translation competent HIV-1 reservoir in vertically infected children and adolescents	Oral abstract session with live Q&A	Cellular and tissue reservoirs of HIV/SIV